Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

Closing Bell: Sensex, Nifty end off day#39;s low; RIL, Infosys, Axis Bank rebound

2018-02-19 moneycontrol
3:30 pm Market Closing: Benchmark indices closed below their 100-day moving average, with the Sensex losing 236.10 points to 33,774.66 and the Nifty down 73.90 points at 10,378.40 after recovered from day's low. (34-0)

Market Live: Sensex dips 300 pts, Nifty below 10,400; banks, metals drag

2018-02-19 moneycontrol
3:18 pm Market Update: Benchmark indices recovered from day's low as Reliance Industries, Infosys, Axis Bank, Kotak Mahindra Bank, HDFC Bank and Yes Bank traded in the green. (32-0)

Market Live: Sensex dips 400 pts, Nifty below 10,400; PSU banks fall 4-10%

2018-02-19 moneycontrol
12:54 pm Market Update: Bears took complete control of Dalal Street as the Sensex was down 402.18 points or 1.18 percent at 33,608.58 as all sectoral indices traded in the red. (12-0)

Market Live: Nifty tests 10,400 amid volatility; all sectoral indices in the red

2018-02-19 moneycontrol
11:01 am Market Outlook: Volatility persisted on Monday with the Sensex falling over 200 points from the day’s high. But, Ratnesh Kumar of BOBCAPS is not worried. (12-0)

Natco Pharma rallies 6% on zero observations for Mekaguda unit post USFDA inspection

2018-02-19 moneycontrol
Natco Pharma shares rallied as much as 6.4 percent in morning Monday after the Mekaguda facility received zero observations from the US health regulator.

Natco Pharma Limited - Press Release

2018-02-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Natco Pharma Limited - News Verification

2018-02-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Natco Pharma Limited - Reply to Clarification- Financial results

2018-02-09 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Natco Pharma Limited - Investor Presentation

2018-02-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Natco Pharma Limited - Clarification - Financial Results

2018-02-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Top buzzing midcap stocks to trade on February 7

2018-02-07 moneycontrol
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today -- Natco Pharma, Cadila, HEG, Bharat Electronics, Lumax, Thermax, and KEC International.

Natco Pharma Q3 net up 11% at Rs 2.17 billion

2018-02-06 business-standard
Natco Pharma Limited has reported a 11.54 percent increase in net profit at Rs 2.17 billion for the quarter ended December 2017 as compared with Rs 1.95 billion in the corresponding quarter previous year.

Natco Pharma Limited - Press Release

2018-02-06 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Natco Pharma Limited - Dividend

2018-02-06 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Natco Pharma Limited - Record Date

2018-02-06 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.